XML 150 R124.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segments of Business - Schedule of Segment Information (Details) - USD ($)
$ in Millions
1 Months Ended 12 Months Ended
Jul. 31, 2022
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Segment revenues        
Total revenues   $ 308,951 $ 276,711 $ 263,966
Segment operating profit (loss)        
Total operating profit (loss)   4,892 5,025 3,370
Corporate expenses, net   (851) (147) (1,073)
Loss on debt extinguishment   0 0 (191)
Interest expense   (252) (248) (178)
Income from continuing operations before income taxes   3,789 4,630 1,928
Segment depreciation and amortization        
Total depreciation and amortization   635 608 760
Segment expenditures for long-lived assets        
Total expenditures for long-lived assets   687 558 535
Provision for bad debts   819 45 29
Charges (credits) associated with last-in, first-out inventory method   (157) 1 (23)
Restructuring charges   115 209 245
Charge for remeasurement to fair value   0 0 1,509
Net gains (losses) on investments in equity securities   (24) (36) 98
Gain on derivative termination     (97)  
Tax Receivable Agreement (“TRA”)        
Segment expenditures for long-lived assets        
Gain for early termination of tax receivable agreement     126  
German Wholesale Business        
Segment expenditures for long-lived assets        
Gain from sale of equity method investment       42
Held-for-sale | E.U. Businesses (Disposal Group)        
Segment expenditures for long-lived assets        
Charge for remeasurement to fair value     438 438
Held-for-sale | U.K. Businesses (Disposal Group)        
Segment expenditures for long-lived assets        
Charge for remeasurement to fair value       1,200
Disposal Group, Disposed of by Sale, Not Discontinued Operations | E.U. Businesses (Disposal Group)        
Segment expenditures for long-lived assets        
Charge for remeasurement to fair value     (66) $ (66)
Operating Segments | German Wholesale Business        
Segment expenditures for long-lived assets        
Noncontrolling interest (percent)       30.00%
Corporate        
Segment depreciation and amortization        
Total depreciation and amortization   121 124 $ 117
Segment expenditures for long-lived assets        
Total expenditures for long-lived assets   229 173 137
Restructuring charges   55 83 100
Corporate | National Prescription Opiate Litigation        
Segment expenditures for long-lived assets        
Litigation settlement payments   35 36 130
Corporate | Held-for-sale | E.U. Businesses (Disposal Group)        
Segment expenditures for long-lived assets        
Charge for remeasurement to fair value     (306) 55
Corporate | Held-for-sale | U.K. Businesses (Disposal Group)        
Segment expenditures for long-lived assets        
Charge for remeasurement to fair value       42
Corporate | National Prescription Opiate Litigation        
Segment expenditures for long-lived assets        
Loss contingency accrual, period increase (decrease)   73 (8) 274
U.S. Pharmaceutical        
Segment revenues        
Total revenues   278,739 240,616 212,149
Segment expenditures for long-lived assets        
Provision for bad debts   725    
U.S. Pharmaceutical | Operating Segments        
Segment operating profit (loss)        
Total operating profit (loss)   2,786 3,206 2,879
Segment depreciation and amortization        
Total depreciation and amortization   229 212 228
Segment expenditures for long-lived assets        
Total expenditures for long-lived assets   $ 193 $ 154 $ 137
Revenue derived from services, percentage (less than)   1.00% 1.00% 1.00%
Net cash proceeds from settlements   $ 244 $ 129 $ 46
Charges (credits) associated with last-in, first-out inventory method   (157) 1 (23)
Gain from sale of equity method investment     142  
Proceeds from sale of equity method investment $ 179      
Restructuring charges   17 38 35
U.S. Pharmaceutical | Operating Segments | New York Opioid Tax Surcharge        
Segment expenditures for long-lived assets        
Charge recorded related to Company's share of the litigation settlement     18  
U.S. Pharmaceutical | Operating Segments | National Prescription Opiate Litigation        
Segment expenditures for long-lived assets        
Loss contingency accrual, period increase (decrease)   74    
Prescription Technology Solutions        
Segment revenues        
Total revenues   4,769 4,387 3,864
Prescription Technology Solutions | Operating Segments        
Segment operating profit (loss)        
Total operating profit (loss)   835 566 500
Segment depreciation and amortization        
Total depreciation and amortization   84 77 82
Segment expenditures for long-lived assets        
Total expenditures for long-lived assets   $ 31 $ 35 $ 10
Revenue derived from services, percentage (less than)   39.00% 39.00% 39.00%
Restructuring charges   $ 11 $ 43 $ 25
Medical-Surgical Solutions        
Segment revenues        
Total revenues   11,313 11,110 11,608
Segment expenditures for long-lived assets        
Inventory write-down charges     164  
Medical-Surgical Solutions | Operating Segments        
Segment operating profit (loss)        
Total operating profit (loss)   952 1,117 959
Segment depreciation and amortization        
Total depreciation and amortization   84 80 129
Segment expenditures for long-lived assets        
Total expenditures for long-lived assets   $ 159 $ 117 $ 74
Revenue derived from services, percentage (less than)   3.00% 3.00% 3.00%
Restructuring charges   $ 11 $ 10 $ 9
International        
Segment revenues        
Total revenues   14,130 20,598 36,345
International | Operating Segments        
Segment operating profit (loss)        
Total operating profit (loss)   319 136 (968)
Segment depreciation and amortization        
Total depreciation and amortization   117 115 204
Segment expenditures for long-lived assets        
Total expenditures for long-lived assets   $ 75 $ 79 $ 177
Revenue derived from services, percentage (less than)   8.00% 8.00% 8.00%
Restructuring charges   $ 21 $ 35 $ 76
International | Operating Segments | Held-for-sale | E.U. Businesses (Disposal Group)        
Segment expenditures for long-lived assets        
Charge for remeasurement to fair value     $ 240 383
International | Operating Segments | Held-for-sale | U.K. Businesses (Disposal Group)        
Segment expenditures for long-lived assets        
Charge for remeasurement to fair value       1,100
International | Operating Segments | Held-for-sale | German Wholesale Business | Walgreens Boots Alliance Joint Venture        
Segment expenditures for long-lived assets        
Gain from sale of equity method investment       42
International | Operating Segments | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Canadian Health Benefit Claims Management and Plan Administrative Services Business        
Segment expenditures for long-lived assets        
Pre-tax gain on sale of business       $ 59